Virios Therapeutics Llc Stock Analysis

Virios Stock Analysis Notes

The book value of the company was at this time reported as 0.2. The company recorded a loss per share of 0.28. Virios Therapeutics Llc had not issued any dividends in recent years. Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia. Virios Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. For more information please call Gregory Duncan at 866 620 8655 or visit https://www.virios.com.

Virios Therapeutics Llc Investment Alerts

Virios Therapeutics Llc Upcoming and Recent Events

Virios Largest EPS Surprises

View All Earnings Estimates

Virios Therapeutics Thematic Classifications

Virios Stock Institutional Investors

Note, although Virios Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Virios Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Virios Therapeutics's market, we take the total number of its shares issued and multiply it by Virios Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Virios Profitablity

Management Efficiency

Virios Therapeutics Llc has return on total asset (ROA) of (0.5432) % which means that it has lost $0.5432 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9514) %, meaning that it created substantial loss on money invested by shareholders. Virios Therapeutics' management efficiency ratios could be used to measure how well Virios Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.33. The Virios Therapeutics' current Return On Capital Employed is estimated to increase to -1.36. The Virios Therapeutics' current Net Tangible Assets is estimated to increase to about 10.7 M, while Total Assets are projected to decrease to under 4 M.

Technical Drivers

As of the 25th of April, Virios Therapeutics has the Risk Adjusted Performance of (0.02), variance of 95.79, and Coefficient Of Variation of (2,129). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Virios Therapeutics Llc, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Virios Therapeutics Llc, which can be compared to its competition. Please validate Virios Therapeutics Llc market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Virios Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 0.43 per share. As Virios Therapeutics Llc is a penny stock we also advise to double-check its jensen alpha numbers.

Virios Therapeutics Llc Price Movement Analysis

Virios Therapeutics Llc Insider Trading Activities

Virios Therapeutics Predictive Daily Indicators

Virios Therapeutics Forecast Models

Virios Therapeutics' time-series forecasting models are one of many Virios Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Virios Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Virios Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Virios shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Virios Therapeutics. By using and applying Virios Stock analysis, traders can create a robust methodology for identifying Virios entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Virios analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Virios analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Virios Therapeutics Llc stock analysis indicators help investors evaluate how Virios Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Virios Therapeutics shares will generate the highest return on investment. By understating and applying Virios Therapeutics stock analysis, traders can identify Virios Therapeutics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virios Therapeutics Llc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stocks Directory module to find actively traded stocks across global markets.

When running Virios Therapeutics' price analysis, check to measure Virios Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virios Therapeutics is operating at the current time. Most of Virios Therapeutics' value examination focuses on studying past and present price action to predict the probability of Virios Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virios Therapeutics' price. Additionally, you may evaluate how the addition of Virios Therapeutics to your portfolios can decrease your overall portfolio volatility.

Is Virios Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virios Therapeutics. If investors know Virios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virios Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Virios Therapeutics Llc is measured differently than its book value, which is the value of Virios that is recorded on the company's balance sheet. Investors also form their own opinion of Virios Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Virios Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virios Therapeutics' market value can be influenced by many factors that don't directly affect Virios Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Virios Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virios Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virios Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.